LAZARI CAPITAL MANAGEMENT, INC.

Position in ABBV — AbbVie Inc.

CIK 1986389 WOODLAND HILLS, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$4,049,894

+$533,516 QoQ

Shares Held

16,094

-0.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.41%

of 13F equity value

Holder Rank

#1,450

of 4,153 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LAZARI CAPITAL MANAGEMENT, INC. holds $11,558,274 across 8 Drug Manufacturers - General names. ABBV ranks #1 (35.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	16,094	$4,049,894
2	JNJ	Johnson & Johnson	6,179	$1,569,280
3	PFE	Pfizer Inc	64,489	$1,552,895
4	LLY	ELI LILLY & Co	1,119	$1,342,162
5	BMY	Bristol Myers Squibb Co	17,208	$991,524
6	MRK	Merck & Co., Inc.	5,710	$733,735
7	AMGN	Amgen Inc	1,870	$677,164
8	GSK	GSK plc	12,240	$641,620

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,049,894	16,094	-0.5%	Shares	Sole	2026-07-23
2026-03-31	$3,516,378	16,168	-0.2%	Shares	Sole	2026-04-24
2025-12-31	$3,700,167	16,194	+0.0%	Shares	Sole	2026-01-29
2025-09-30	$3,749,095	16,192	-0.3%	Shares	Sole	2025-10-28
2025-06-30	$3,014,097	16,238	+0.0%	Shares	Sole	2025-07-17
2025-03-31	$3,401,138	16,233	-1.7%	Shares	Sole	2025-04-23
2024-12-31	$2,933,293	16,507	-5.2%	Shares	Sole	2025-01-24
2024-09-30	$3,437,731	17,408	-0.9%	Shares	Sole	2024-10-22
2024-06-30	$3,013,091	17,567	-1.9%	Shares	Sole	2024-09-09
2024-03-31	$3,261,411	17,910	-1.5%	Shares	Sole	2024-06-24
2023-12-31	$2,816,579	18,175	-1.0%	Shares	Sole	2024-02-27
2023-09-30	$2,737,039	18,362	-2.6%	Shares	Sole	2023-11-07
2023-06-30	$2,538,717	18,843	—	Shares	Sole	2023-07-20
No filing history on record for this holder in this stock.